Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis
Authors:
- 7 April 2020
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 127, 108978
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30 CA008748)
This publication has 34 references indexed in Scilit:
- Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Quantifying the impact of between‐study heterogeneity in multivariate meta‐analysesStatistics in Medicine, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Radiological Changes After Stereotactic Radiotherapy for Stage I Lung CancerJournal of Thoracic Oncology, 2011
- Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)Lung Cancer, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body RadiotherapyJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumorsInternational Journal of Clinical Oncology, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002